• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Fortune 500
    • Fortune 500
    • Fortune Sea 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place To Work
  • Tech
    • Tech
    • Ai
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-suite
    • Ceo Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

    Page 87 of 100

  • General Economy As Persistent Swiss Franc Strength Keeps Consumer Prices FallingHealth

    Guns Are the Third Leading Cause of Child Death in America

    By Sy Mukherjee
  • Heart disease kills one in four Americans.Health

    Could a Vaccine Prevent High Cholesterol and Heart Disease?

    By Sy Mukherjee
  • Health

    Brainstorm Health Daily: June 20, 2017

    By Clifton Leaf and Sy Mukherjee
  • Attorney general Loretta Lynch said the department will issue a new plan next week.Health

    The Opioid Epidemic Is a Middle Class Problem, Too

    By Sy Mukherjee
  • Health

    Brainstorm Health Daily: June 19, 2017

    By Clifton Leaf and Sy Mukherjee
  • Mylan NV EpiPen 2-Pak medication sits on a table inside a pharmacy in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016.Health

    Will the Newest EpiPen Competitor Steal Even More Market Share from Mylan?

    By Sy Mukherjee
  • Trading On The Floor Of The NYSE As U.S. Stocks FallHealth

    Why Cancer Biotech Clovis Oncology’s Stock Is Soaring

    By Sy Mukherjee
  • Operations Inside An Amazon.com Inc. Fulfillment Center On Cyber MondayHealth

    Why Amazon’s Whole Foods Deal Is Slamming Pharma Stocks, Too

    By Sy Mukherjee
  • Health

    Brainstorm Health Daily: June 16, 2017

    By Clifton Leaf and Sy Mukherjee
  • Starchy foodHealth

    Does Eating French Fries Really Double Your Early Death Risk?

    By Sy Mukherjee
  • Health

    Brainstorm Health Daily: June 15, 2017

    By Clifton Leaf and Sy Mukherjee
  • Steve ScaliseHealth

    There Have Been More Than 150 Mass Shootings in America This Year

    By Sy Mukherjee
  • Health

    Brainstorm Health Daily: June 14, 2017

    By Clifton Leaf and Sy Mukherjee
  • House Holds Hearing On Flint Water CrisisHealth

    Michigan’s Health Chief Charged With Manslaughter for the Flint Water Crisis

    By Sy Mukherjee
  • SWITZERLAND-ECONOMY-TRANSPORT-DISTRIBUTIONHealth

    How Drones Could Become the New Ambulances for Heart Attack Patients

    By Sy Mukherjee
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.